Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, Julia, Smagris, Eriks, Stender, Stefan, Nordestgaard, Børge G, Zhou, Heather H, Tybjærg-Hansen, Anne, Vogt, Thomas F, Hobbs, Helen H +1 more·2014·Nature Genetics

DOI 10.1038/ng.2901

Cited by (1,001)

Items 401–500 of 1,001

3D culture models to study pathophysiology of steatotic liver disease
Andrea Marco Caddeo, Samantha Maurotti, Lohitesh Kovooru, Stefano Romeo · 2024 · Atherosclerosis
The contribution of genetics and epigenetics to MAFLD susceptibility
Vittoria Moretti, Stefano Romeo, Luca V. C. Valenti · 2024 · Hepatology International
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Consolato Maria Sergi · 2024 · International Journal of Molecular Sciences
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
Panu K. Luukkonen, Sami U. Qadri, Tiina E. Lehtimäki, Anne Juuti, Henna E. Sammalkorpi, Anne K. Penttilä, Antti Hakkarainen, Marju Orho‐Melander, Johanna T. Arola, Hannele Yki‐Järvinen · 2020 · The Journal of Clinical Endocrinology & Metabolism
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Xiaoli Pan, Yanqiao Zhang · 2022 · Chinese Medical Journal
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gómez, M Serra Cusidó, Alba Jiménez-Masip, Sven Francque et al. · 2024 · Clinical Gastroenterology and Hepatology
Pediatric Non-alcoholic Fatty Liver Disease
Vikas Uppal, Sana Mansoor, Katryn N. Furuya · 2016 · Current Gastroenterology Reports
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a
Lei Yu, Joanne A. Hoogerland, Vincent W. Bloks, Trijnie Bos, Aycha Bleeker, Henk Wolters, Justina Clarinda Wolters, Brenda S. Hijmans, Theo H. van Dijk, Rachel Thomas et al. · 2020 · Hepatology
PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport
Hubert Peng, Tzu-Yuan Chiu, Yu-Jen Liang, CHIA-JEN LEE, Chih-Syuan Liu, Ching‐Shu Suen, Jeffrey J.-Y. Yen, Hung‐Ta Chen, Ming‐Jing Hwang, M. Mahmood Hussain et al. · 2020 · Journal of Biological Chemistry
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
D. Ramai, Waqqas Tai, Michelle Rivera, A. Facciorusso, N. Tartaglia, M. Pacilli, A. Ambrosi, C. Cotsoglou, R. Sacco · 2021 · Biomedicines
The Endless Sources of Hepatocellular Carcinoma Heterogeneity
M. Bárcena-Varela, A. Lujambio · 2021 · Cancers
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease
Rafael Paternostro, Katharina Staufer, Stefan Traussnigg, Albert Friedrich Stättermayer, Emina Halilbasic, Omar Keritam, Elias Laurin Meyer, Judith Stift, Fritz Wrba, Bence Sipos et al. · 2021 · Hepatology International
The Genetics of Pediatric Nonalcoholic Fatty Liver Disease
Nidhi P. Goyal, Jeffrey B. Schwimmer · 2017 · Clinics in Liver Disease
Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants
Shen Chen, Juan Pang, Rong Huang, Hongliang Xue, Xu Chen · 2023 · Hepatology International
Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut–liver axis
Xiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, Chuanfa Liu, Cong Liang, Hye Won Lee, Queena Wing-Yin Ng, Yi Zhao, Fenfen Ji, Yunfei Zhou et al. · 2025 · Nature Metabolism
Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
Yiying Pei, George Boon‐Bee Goh · 2025 · Gut and Liver
Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease
Mingfeng Xia, Hannele Yki‐Järvinen, Hua Bian, Huandong Lin, Hongmei Yan, Xinxia Chang, You Zhou, Xin Gao · 2016 · PLoS ONE
CRISPR/Cas9: at the cutting edge of hepatology
Francis P. Pankowicz, Kelsey E. Jarrett, William R. Lagor, Karl‐Dimiter Bissig · 2017 · Gut
American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults
Eric R. Kallwitz, Bamidele O. Tayo, Mark H. Kuniholm, Jianwen Cai, Martha L. Daviglus, Richard Cooper, Scott J. Cotler · 2019 · Clinical Gastroenterology and Hepatology
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
Alessia Di Costanzo, Lucia Pacifico, Laura D’Erasmo, Luca Polito, Michele Di Martino, Francesco Massimo Perla, Ludovica Iezzi, Claudio Chiesa, Marcello Arca · 2019 · International Journal of Molecular Sciences
Serum lipopolysaccharides predict advanced liver disease in the general population
Ville Männistö, Martti A. Färkkilä, Pirkko J. Pussinen, Antti Jula, Satu Männistö, Annamari Lundqvist, Liisa M Valsta, Veikko V Salomaa, Markus Perola, Fredrik O. Åberg · 2019 · JHEP Reports
Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
Stefan Andrei Chiriac, C Stanciu, Irina Gîrleanu, Camelia Cojocariu, Catalin Victor Sfarti, Ana-Maria Sîngeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia et al. · 2021 · Canadian Journal of Gastroenterology and Hepatology
Allele-specific variation atAPOEincreases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer’s disease and myocardial infarction
Nicholette D. Palmer, Bratati Kahali, Annapurna Kuppa, Yanhua Chen, Xiaomeng Du, Mary Furlan Feitosa, Lawrence F. Bielak, Jeffrey R. O’Connell, Solomon K. Musani, Xiuqing Guo et al. · 2021 · Human Molecular Genetics
Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
Zong Miao, Kristina M. Garske, David Z. Pan, Amogha Koka, Dorota Kamińska, Ville Männistö, Janet S. Sinsheimer, Jussi Pihlajamäki, Päivi Pajukanta · 2021 · Human Genetics and Genomics Advances
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep Antoni Tur, Cristina Bouzas · 2023 · Nutrients
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease
Huaying Wu, Jingjing Chen, Shuyuan Guo, Jinhao Deng, Zimeng Zhou, Xuan Zhang, Tiantian Qi, Fei Yu, Qi Liang Yang · 2025 · Gut Microbes
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome
Albert Friedrich Stättermayer, Stefan Traussnigg, Elmar Stephan Aigner, Christian Kienbacher, Ursula Huber-Schönauer, Petra Steindl‐Munda, Andreas Stadlmayr, Friedrich Wrba, Michael A Trauner, Christian Datz et al. · 2016 · Journal of Trace Elements in Medicine and Biology
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca · 2019 · Pediatric Research
Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children
Marta Flisiak‐Jackiewicz, Dariusz Marek Lebensztejn · 2019 · Clinical and Experimental Hepatology
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Connor A. Emdin, Mary Haas, Amit V. Khera, Krishna G. Aragam, Mark D. Chaffin, Lan Jiang, Wei‐Qi Wei, QiPing Feng, Juha M Karjalainen, Aki Samuli Havulinna et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
Marios Zisis, Maria Eleni Chondrogianni, Θεόδωρος Ανδρουτσάκος, Ilias Rantos, Evangelos K. Oikonomou, Antonios Chatzigeorgiou, Eva N. Kassi · 2025 · Biomolecules
Genetic determinants of hepatic steatosis and serum cytokeratin‐18 fragment levels in Taiwanese children
Yu‐Cheng Lin, Pi‐Feng Chang, Mei‐Hwei Chang, Yen‐Hsuan Ni · 2018 · Liver International
Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
Alice Emma Taliento, Marcello Dallio, Alessandro Federico, Daniele Prati, Luca V. C. Valenti · 2019 · International Journal of Environmental Research and Public Health
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
Yen‐Ying Chen, Matthew M. Yeh · 2020 · Journal of the Formosan Medical Association
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
Kechagias, Stergios, Ekstedt, Mattias, Simonsson, Christian, Nasr, Patrik · 2022 · Hormones
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
Agostino Di Ciaula, Leonilde Bonfrate, Marcin Jan Krawczyk, Gema Frühbeck, Piero Portincasa · 2022 · International Journal of Molecular Sciences
Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per I Stal, Hannes Hagström · 2022 · Liver International
Omega-3 intake is associated with liver disease protection
Mara Sophie Vell, Kate Townsend Creasy, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Kai Markus Schneider, Carolin Victoria Schneider · 2023 · Frontiers in Public Health
Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
Andrea Marco Caddeo, Stefano Romeo · 2024 · Clinical and Molecular Hepatology
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Chenyang Mu, Sijie Wang, Zenghan Wang, Jian Tan, Hao-zan Yin, Yuefan Wang, Zhihui Dai, Dongyang Ding, Fu‐Chi Yang · 2024 · Annals of Hepatology
PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
Jinzhi Wang, Haixia Cao, Jian-Neng Chen, Qin Pan · 2018 · World Journal of Clinical Cases
Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility
Yan Xia, Chunxia Huang, Guangyi Li, Kai-Hua Chen, Han Li, Liang Tang, Huaiqing Luo, Meihua Bao · 2019 · Clinics and Research in Hepatology and Gastroenterology
Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD
Ghideon Z. Ezaz, Hirsh D. Trivedi, Margery A. Connelly, CLAUDIA M. FILOZOF, Kellie Howard, Mark L Parrish, Mi-Sung Kim, Mark A. Herman, Imad Ahmad Nasser, Nezam H. Afdhal et al. · 2020 · Hepatology Communications
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Jake Peter Mann, Maik Pietzner, Laura B. L. Wittemans, Emmanuela De Lucia Rolfe, Nicola D. Kerrison, Fumiaki Imamura, Nita G. Forouhi, Eric B. Fauman, Michael Allison, Jules L Griffin et al. · 2020 · Human Molecular Genetics
NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study
Mingfeng Xia, Shuai Ma, Qingxia Huang, Hailuan Zeng, Jieyu Ge, Wenjie Xu, Qi Wu, Li Wu, Xiaoming Li, Hui Ma et al. · 2022 · Alimentary Pharmacology & Therapeutics
TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease
Lizhen Chen, Harry Hua‐Xiang Xia, Yongning Xin, Zhonghua Lin, Shiying Xuan · 2015 · Journal of Clinical and Translational Hepatology
SUGP1 is a novel regulator of cholesterol metabolism
Mee J. Kim, Chi-Yi Yu, Elizabeth Theusch, Devesh Naidoo, Kristen Stevens, Yu‐Lin Kuang, Erin G. Schuetz, Amarjit S. Chaudhry, Marisa Wong Medina · 2016 · Human Molecular Genetics
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease
Daniel Steinacher, Thierry Claudel, Michael A Trauner · 2017 · Digestive Diseases
Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells
Ruhanen, Hanna, Nidhina Haridas, P.A., Eskelinen, Eeva-Liisa, Eriksson, Ove, Olkkonen, Vesa M., Käkelä, Reijo · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Jiang Chang, Jianbo Tian, Ying Zhu, Rong Zhong, Kan Zhai, Jiaoyuan Li, Juntao Ke, Qiangqiang Han, Jiao Lou, Wei Chen et al. · 2018 · Nature Communications
Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
Gebran W. Khneizer, Syed Rizvi, Samer Gawrieh · 2020 · Advances in experimental medicine and biology
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi · 2021 · Cells
TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
Xueying Li, Zheng Liu, Li Li, Haijun Wang, Hui Wang · 2022 · Frontiers in Endocrinology
Advances in the genetics of nonalcoholic fatty liver disease
Veeral H. Ajmera, Rohit Seth Loomba · 2023 · Current Opinion in Gastroenterology
Sex-Specific Differences in Lipoprotein Production and Clearance
Donna Conlon, Francine K. Welty, Gissette Reyes‐Soffer, Jaume Amengual · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
TM6SF2: A novel target for plasma lipid regulation
Tingting Li, Tao‐Hua Li, Juan Peng, Bei He, Lu-Shan Liu, Dangheng Wei, Zhi‐Sheng Jiang, Xi‐Long Zheng, Zhi‐Han Tang · 2017 · Atherosclerosis
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers
Marcin Jan Krawczyk, Heike Bantel, Monika Rau, Jörn Markus Schattenberg, F Grünhage, Anita Pathil, Münevver Demir, Johannes Kluwe, Tobias Boettler, Susanne Nicole Weber et al. · 2018 · Journal of Human Genetics
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
Yu‐Cheng Lin, Chi-Chien Wu, Yen‐Hsuan Ni · 2020 · Frontiers in Pediatrics
Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease
Thomas J. Velenosi, Gil Ben Yakov, Maren Catherina Podszun, Julian Hercun, Ohad Etzion, Shanna B. Yang, Cathy Nadal, Vanessa Haynes–Williams, Wen‐Chun A. Huang, Lila González-Hódar et al. · 2022 · Gastroenterology
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
Gaoxuan Shao, Ying Liu, Lu Lu, Guangtao Zhang, Wenjun Zhou, Tao Wu, Lei Wang, Hanchen Xu, Guang Ji · 2022 · Frontiers in Pharmacology
Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease
Elizabeth Jane Parks, Hannele Yki‐Järvinen, Meredith A. Hawkins · 2017 · Journal of Clinical Investigation
The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
Zhengtao Liu, Shuping Que, Lin Zhou, Shusen Zheng, Stefano Romeo, Adil Mardinoğlu, Luca V. C. Valenti · 2017 · Scientific Reports
Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults?
Emer Fitzpatrick, Anil Kumar Dhawan · 2019 · Journal of Clinical and Experimental Hepatology
Pleiotropic mapping and annotation selection in genome-wide association studies with penalized Gaussian mixture models
Ping Zeng, Xingjie Hao, Xiang Zhou · 2018 · Bioinformatics
The Liver in Children With Metabolic Syndrome
Ebe D’Adamo, Valeria Castorani, Valério Nobili · 2019 · Frontiers in Endocrinology
Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease
Montgomery Blencowe, Tilan Karunanayake, Julian R. Wier, Neil Hsu, Xia Yang · 2019 · Genes
Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice
Yang Pan, Youlin Wang, Weiqing Tang, Weiwei Sun, Yinyan Ma, Shu Lin, Jia Jing, Long Jiang, Hang Shi, Zhiyuan Song et al. · 2020 · Scientific Reports
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms
Christian A. Hudert, Leon Anton Adams, Anna Alisi, Quentin Mark Anstee, Annalisa Crudele, Laura G. Draijer, EU‐PNAFLD investigators, Samuel Furse, Jan Georg Hengstler, Benjamin Jenkins et al. · 2022 · Hepatology Communications
Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
Muhammad Imran Ahmad, Muhammad Umair Khan, Sudha Kodali, Akshay Shetty, Suzanne M. Bell, David W. Victor · 2022 · Journal of Hepatocellular Carcinoma
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
Mohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, Clifton G. Fulmer, Joseph M. Luna, Jérémie Le Pen, Matteo Tardelli, Brandon S. Razooky, Inna Ricardo-Lax, Chenhui Zou et al. · 2022 · Cell Reports
Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians
Shiu Lun Au Yeung, Maria Carolina Borges, Tommy Hon Ting Wong, Debbie A. Lawlor, Catherine Mary Schooling · 2022 · International Journal of Epidemiology
Fatty Liver Disease
DINA G. TINIAKOS, Quentin Mark Anstee, Alastair D. Burt · 2017 · Elsevier eBooks
Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs
Cene Skubic, Živa Drakulić, Damjana Rozman · 2018 · Expert Opinion on Drug Metabolism & Toxicology
Exome Sequencing in Clinical Hepatology
Sílvia Vilarinho, Pramod Kumar Mistry · 2019 · Hepatology
Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
Jian-Ting Wu, Shousheng Liu, Xiangjun Xie, Qun Liu, Yongning Xin, Shiying Xuan · 2020 · Lipids in Health and Disease
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
Quelson Coelho Lisboa, Mateus Jorge Nardelli, Patrícia de Araújo Pereira, Débora Marques de Miranda, Stephanie Nunes Ribeiro, Raíssa Soares Neves da Costa, Camila Azevedo Versiani, Paula Vieira Teixeira Vidigal, Teresa Cristina Abreu Ferrari, Cláudia Alves Couto · 2020 · World Journal of Hepatology
WGCNA‐Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease
Folai Zeng, Meijie Shi, Huanming Xiao, Xiaoling Chi · 2021 · BioMed Research International
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
Francesco Baratta, Laura D’Erasmo, Simone Bini, Daniele Pastori, Francesco Angelico, Maria Del Ben, Marcello Arca, Alessia Di Costanzo · 2022 · Atherosclerosis
Lipid and Lipoprotein Metabolism in Liver Disease
Ashwini Arvind, Stephanie A. Osganian, David E. Cohen, Kathleen E. Corey · 2015 · MDText.com, Inc. eBooks
Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case–control study
Ioanna Panagiota Kalafati, Maria Dimitriou, Dimitra Borsa, Jiannis Vlachogiannakos, Konstantinos Revenas, Alexander D. Kokkinos, S.D. Ladas, George V. Dedoussis · 2018 · European Journal of Nutrition
Using CRISPR/Cas9 to model human liver disease
Michele Alves‐Bezerra, Nika Furey, Collin G. Johnson, Karl‐Dimiter Bissig · 2019 · JHEP Reports
Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis
Julia Kozlitina · 2020 · Gastroenterology Clinics of North America
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi et al. · 2021 · International Journal of Molecular Sciences
Rare and low-frequency variants in human common diseases and other complex traits
Guillaume Lettre · 2014 · Journal of Medical Genetics
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki et al. · 2015 · Gut and Liver
Genetics of alcoholic liver disease and non-alcoholic steatohepatitis
Emma Scott, Quentin Mark Anstee · 2018 · Clinical Medicine
Gut microbiota in MAFLD: therapeutic and diagnostic implications
Waleed Alghamdi, Mahmoud Hisham Mosli, Saleh A. Alqahtani · 2024 · Therapeutic Advances in Endocrinology and Metabolism
Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis
Arun Jayant Sanyal, Jörg Täubel, Prajakta S. Badri, Sarah E. Bond Newton, Nune Makarova, Weizhi Zhao, Swati Duggal, Farshad Kajbaf, Benjamin A. Olenchock, John M. Gansner · 2025 · Journal of Hepatology
Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study
Marcin Jan Krawczyk, Ewa Stachowska, Piotr Milkiewicz, Frank Lammert, Małgorzata Milkiewicz · 2016 · Digestion
Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
Silvia C. Sookoian, Cristian Rohr, Adrián Salatino, Hernán Dopazo, Tomas Fernández Gianotti, Gustavo Osvaldo Castaño, Carlos Jose Pirola · 2017 · Oncotarget
Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities
Govardhan Bale, Urmila Steffie Avanthi, Vishnubhotla Venkata Ravi Kanth, Padaki Nagaraja Rao, Mithun Sharma, Mitnala Sasikala, D. Nageshwar Reddy · 2017 · World Journal of Hepatology
Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani Kumar Singal, Sanjaya Kumar Satapathy · 2018 · Journal of Clinical and Experimental Hepatology
Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC
Ken Liu, Geoffrey William McCaughan · 2018 · Advances in experimental medicine and biology
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos · 2020 · Journal of Clinical and Translational Hepatology
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, C. Loguercio, Alessandro Federico · 2021 · Nutrients
Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population
Magda A. Shaheen, Katrina M. Schrode, Deyu Pan, Dulcie Kermah, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia Michael Najjar, Theodore C. Friedman · 2021 · Frontiers in Medicine
Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma
Yetirajam Rajesh, Devanand Sarkar · 2020 · Cancers
Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtypes
Miriam S. Udler, Jaegil Kim, Marcin von Grotthuss, Sílvia Bonàs‐Guarch, Josep Maria Mercader, Joanne B. Cole, Joshua Chiou, Christopher D. Anderson, Michael Boehnke, Markku Laakso et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
Gary Huang, Daniel F. Wallace, Elizabeth Ellen Powell, Tony Manibur Rahman, Paul James Clark, V. Nathan Subramaniam · 2023 · Biomedicines
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Kanuengnit Choochuay, Punna Kunhapan, Apichaya Puangpetch, Sissades Tongsima, Pornpen Srisawasdi, Abhasnee Sobhonslidsuk, Somnuek Sungkanuparph, Mohitosh Biswas, Chonlaphat Sukasem · 2024 · World Journal of Hepatology